Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2026-02-21 @ 9:56 PM
Study NCT ID:
NCT03155932
Status:
TERMINATED
Last Update Posted:
2022-03-24
First Post:
2017-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis
Sponsor:
Arena Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-29
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-11
First Submit QC Date:
None
Study First Post Date:
2017-05-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-01-28
Results First Submit QC Date:
None
Results First Post Date:
2022-03-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-03-24
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-02-28
Last Update Post Date:
2022-03-24
Last Update Post Date Type:
ACTUAL